SpringWorks Therapeutics is a commercial-stage biopharmaceutical company that develops and delivers targeted therapies for individuals afflicted by severe rare diseases and various forms of cancer. The company emphasizes a precision medicine approach, which entails creating customized treatment solutions based on the unique genetic and pathological characteristics of diseases. With a robust pipeline that includes both clinical trials in rare tumors and prevalent genetically defined cancers, SpringWorks leverages its operational expertise and strategic collaborations with industry and academic leaders to drive the development of its innovative therapies. The mission of SpringWorks is to transform patient outcomes by unlocking the full potential of its therapeutic portfolio in its pursuit of impactful clinical solutions.